Skip to main content

Use of Comparative Effectiveness Analysis in Managed Care

Web Exclusives - Practice Management

Rising costs pose a significant challenge to the US healthcare system. Congress, public and private payers, and other stakeholders have a significant interest in using comparative effectiveness research to control healthcare costs and support value-based purchasing. Policymakers continue to examine the framework for this research at the national level, while commercial payers are already comparing the effectiveness of products. Widespread use of comparative effectiveness data could have profound implications for manufacturers as well as the entire healthcare system.1

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 4
Figure 4
Figure 5
Figure 5
Figure 6
Figure 6

The following findings (Figures 1-6) represent responses from a panel of medical and pharmacy directors (N = 73) from national and regional health plans to a survey on the use of comparative effectiveness studies. The survey was conducted during the June 2008 Managed Care Network (MCN) meeting in Washington, DC.2

Notes

1. For more information see Xcenda/AmerisourceBergen Specialty Group Webcast, “Comparative effectiveness: emerging use with public and private payers and potential impact on manufacturers.” May 20, 2008. www.absgwebcasts.com/archive.cfm.

2. MCN is comprised of more than 100 medical and pharmacy directors representing more than 150 million covered lives. MCN conducts payer market research and provides strategic guidance to the pharmaceutical industry. In 2007, MCN became a part of Xcenda/AmerisourceBergen Specialty Group. See www.mcnweb.com.

Related Items
505(b)(2) Drugs: Creating New Chaos for Infusion Centers
Online First published on May 15, 2025 in Practice Management, Oncology
A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022
Yiyu Chen, MS, Patricia R. Wigle, PharmD, Orson Austin, MD, Jeff Jianfei Guo, BPharm, PhD
Web Exclusives published on February 2, 2024 in Original Research, Practice Management, Health Policy and Reform
Employer Disability and Workers’ Compensation Trends for Their Employees With Ophthalmic Conditions in the United States
Richard A. Brook, MS, MBA, Nathan L. Kleinman, PhD, Ian A. Beren, BS
Web Exclusives published on August 21, 2023 in Original Research, Practice Management
Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions
Web Exclusives published on July 13, 2023 in Practice Management
Clinical and Financial Impacts of an Ambulatory Oncology Pharmacist–Based Intravenous Chemotherapy Education and Follow-Up Program
Grant W. Lee, PharmD, BCOP, Joseen J. Chundamala, PharmD, Kerri L. Monahan, PharmD, Judy J. Cho, PharmD, Lydia J. Berry, RPh, PharmD, Christine G. Cambareri, PharmD, BCOP, CSP
Web Exclusives published on July 6, 2023 in Original Research, Practice Management
Last modified: August 30, 2021